“Therapeutic Use of Tolvaptan in Cancer-Related Hyponatremia: Benefits, Risks, and Clinical Guidance” (2026) International Journal of Emerging Research in Applied Medical Sciences, 2(4), pp. 10–18. doi:10.65477/j29hcv64.